Background-Disturbances in pH affect artery function, but the mechanistic background remains controversial. We investigated whether Na ϩ ,HCO 3 Ϫ cotransporter NBCn1, by regulating intracellular pH (pH i ), influences artery function and blood pressure regulation. Methods and Results-Knockout of NBCn1 in mice eliminated Na ϩ ,HCO 3
dency with significant changes at physiological pH i levels. 10 Modulation of eNOS activity by pH i has never been shown in intact arteries or in vivo, and the importance of this phenomenon for cardiovascular function remains to be established.
The rho-kinase regulates VSMC Ca 2ϩ sensitivity by phosphorylation and inactivation of the myosin light chain phosphatase, 22 and rho-kinase-dependent signaling in VSMCs is necessary for development of hypertension to angiotensin-II infusion. 23 Regulation of rho-kinase signaling by pH i has not previously been addressed.
Regulation of pH i depends on membrane acid-base transporters, such as Na ϩ /H ϩ exchangers 24 and Na ϩ ,HCO 3 Ϫ cotransporters. Electroneutral Na ϩ ,HCO 3 cotransport was first demonstrated in VSMCs. 25 Subsequently, NBCn1 (slc4a7) was cloned from rat aorta and human skeletal muscle 26, 27 and characterized as an electroneutral Cl Ϫ -independent Na ϩ ,HCO 3 Ϫ cotransporter. 26 Knockout (KO) studies elucidated its importance for auditory and ocular functions. 28 NBCn1 is the only Na ϩ ,HCO 3 Ϫ cotransporter of the slc4 family found at messenger RNA level in mouse resistance arteries, 9 and is expressed in both VSMCs and ECs. 9, 29 In VSMCs, NBCn1 is responsible for the Na ϩ ,HCO 3 Ϫ cotransport. 9 In ECs, the functional importance of Na ϩ ,HCO 3 Ϫ cotransport has only been investigated in cultured cells. 30, 31 We hypothesized that NBCn1 modulates artery tone and blood pressure control through regulation of pH i . We demonstrate that NBCn1 is crucial for pH i regulation in ECs and VSMCs and maintains NO production and VSMC Ca 2ϩ sensitivity. NBCn1 KO mice are mildly hypertensive at rest, display attenuated blood pressure responses to NO-synthase and rho-kinase inhibition, and are resistant to developing hypertension during angiotensin-II infusion.
Methods
Mice with a targeted disruption of the NBCn1 gene were produced using embryonic stem cells (40G1; Centre for Modeling Human Disease, Toronto, Canada) containing the pMS1 gene trap vector integrated 434 bases upstream of the MEAD start codon. Heterozygous mice were back-crossed into wild-type (WT) C57BL/6J mice for at least 7 generations before the animals were investigated. All animal procedures were approved by the Danish Animal Care and Use Committee under the Danish Ministry of Justice.
Isolated mesenteric arteries from adult mice were mounted in wire myographs and pH i and Ca 2ϩ dynamics investigated using fluorescence confocal or wide-field microscopy. Gene expression was studied using quantitative reverse-transcriptase polymerase chain reaction, Western blot analyses, whole-mount immunofluorescence imaging, and immunogold electron microscopy. Nitric oxide concentrations in arteries were measured intraluminally using NO-sensitive electrodes, whereas NOsynthase activity was determined from the conversion rate of L-arginine to L-citrulline using radioisotopes. Phosphorylation of eNOS at Ser-1177 and of the myosin phosphatase targeting subunit (MYPT) at Thr-850 were investigated by Western blot analyses using phosphospecific antibodies. Rho-kinase activity as a function of pH was measured using an in vitro assay based on a phospho-specific monoclonal antibody. Blood pressure was measured using radiotelemetry or by determining the tail blood volume with a volume-pressure recording sensor and an occlusion tail-cuff.
Data are expressed as meanϮSEM. Unpaired 2-tailed Student t test was used for comparison of 1 variable between 2 groups. To evaluate the effects of 2 variables on the measured variable, we used 2-way ANOVA followed by Bonferroni post tests. When the variable was measured multiple times for each mouse, a repeated measures 2-way ANOVA was employed. Concentration-response relationships were analyzed using sigmoidal curve fits with variable slope and the derived log(EC 50 ), and maximum values were compared with extra sum-of-squares F tests. The genotype and sex distribution of pups were compared using 2 tests. PϽ0.05 was considered statistically significant; n equals number of mice. Statistical analyses were performed using Microsoft Excel 2007 or GraphPad Prism 5.02 software. An expanded Materials and Methods section is included in the online-only Data Supplement.
Results
NBCn1 is expressed in plasma membranes of mouse mesenteric artery VSMCs. 9, 29 The NBCn1 promoter is active in mouse ECs, 29 and we confirmed the expression of NBCn1 in mouse NBCn1 is expressed in mouse mesenteric artery ECs. A, NBCn1 expression was detected in the EC layer of mouse mesenteric arteries using whole-mount immunofluorescence imaging with an antibody against the N-terminus of NBCn1. The periphery of 1 positive EC is highlighted. B, No staining of the EC layer was seen when the primary antibody was preincubated with the immunizing peptide. C, Low magnification electron micrograph showing a collapsed artery fixed in a wire myograph. Opposite, VSMC-containing wall sections are seen with opposing EC layers surrounding the artery lumen (arrow). D, High-magnification electron micrograph of the EC highlighted by a rectangle in panel C. Arrows indicate gold particles associated with the plasma membrane. Some gold particles seemed associated with vesicular structures or invaginations of the cell membrane (arrow heads). No staining was seen when the primary antibody was omitted (not shown). VSMCs indicates vascular smooth muscle cells; ECs, endothelial cells. mesenteric artery ECs using whole-mount immunofluorescence imaging and immunogold electron microscopy ( Figure 1 ). Disruption of the NBCn1 gene eliminated NBCn1 messenger RNA and protein expression in mesenteric arteries (Figure 2A ).
Heterozygous breeding resulted in a nonmendelian distribution (PϽ0.05) with 18.2Ϯ2.1% KO, 27.1Ϯ2.4% WT, and 54.7Ϯ2.7% heterozygous pups among 329 mice genotyped (at 3 weeks of age; online-only Data Supplement Figure Ia) . Thus, the number of NBCn1 KO mice was reduced by one third of the expected number, indicating reduced conception or increased intrauterine or neonatal mortality. No significant effect of NBCn1 KO was seen on the sex distribution of the pups (online-only Data Supplement Figure Ia 
Regulation of pH i in VSMCs
Vascular smooth muscle cells were acidified with the NH 4 ϩ prepulse technique 32 (online-only Data Supplement Figure   II ). Addition of NH 4 Cl elicited abrupt intracellular alkalinization caused by influx of NH 3 followed by a slower acidification due to NH 4 ϩ entry. Washout of NH 4 Cl caused intracellular acidification as rapid efflux of NH 3 left protons to accumulate intracellularly. NH 4 Cl was washed out into a Na ϩ -free solution to inhibit Na ϩ -dependent transport. In arteries from WT mice, the amiloride-insensitive base uptake on readdition of Na ϩ was faster in the presence of CO 2 / HCO 3 Ϫ than in its absence ( Figure 2B , D, and E). This Na ϩand HCO 3 Ϫ -dependent base uptake was abolished in arteries from NBCn1 KO mice ( Figure 2C through E), demonstrating that NBCn1 is responsible for the Na ϩ ,HCO 3 Ϫ cotransport in VSMCs, and no other Na ϩ -dependent HCO 3 Ϫ transporter compensates for the KO of NBCn1.
With CO 2 /HCO 3 Ϫ present, steady-state pH i was 0.14Ϯ0.04 pH units lower in VSMCs from NBCn1 KO compared with WT mice ( Figure 2F ). Removal of CO 2 /HCO 3 Ϫ acidified VSMCs from WT (⌬pH i ϭϪ0.18Ϯ0.05; nϭ6) but not NBCn1 KO mice (⌬pH i ϭϪ0.01Ϯ0.03; nϭ6; PϽ0.01), con- Ϫ cotransporter in VSMCs from mouse mesenteric arteries. A, NBCn1 messenger RNA and protein were not detected in mesenteric arteries from NBCn1 KO mice (nϭ4 -5). B, After an NH 4 ϩ prepulse, VSMCs from WT mice (nϭ5) displayed faster pH i recovery in the presence of CO 2 /HCO 3 Ϫ than in its nominal absence. C, After an NH 4 ϩ prepulse, no difference in pH i recovery rate was seen between VSMCs from NBCn1 KO mice (nϭ5) investigated with or without CO 2 /HCO 3 Ϫ . D, Net Na ϩdependent base uptake in the presence of CO 2 /HCO 3 Ϫ and 600 mol/L amiloride calculated at average pH i values between 6.4 and 6.7. Na ϩ ,HCO 3 Ϫ cotransport was abolished in arteries from NBCn1 KO mice. E, Net base uptake in the absence of CO 2 /HCO 3 Ϫ with or without 600 mol/L amiloride calculated at an average pH i of 6.4. Na ϩ /H ϩ exchange (HCO 3 Ϫ free) was enhanced in VSMCs from NBCn1 KO compared with WT mice. F, Vascular smooth muscle cells from NBCn1 KO displayed reduced steady-state pH i compared with WT mice (nϭ6) in the presence but not in the absence of CO 2 /HCO 3 Ϫ . Comparisons in panels A and D were made with 2-tailed unpaired Student t-tests. In panel E and F, repeated measures 2-way ANOVA was performed followed by Bonferroni post tests. *PϽ0.05, **PϽ0.01, ***PϽ0.001. pH i indicates intracellular pH; NS, not significantly different versus WT.
firming that the acidification is caused by inhibition of Na ϩ ,HCO 3 Ϫ cotransport. We measured Na ϩ /H ϩ -exchange activity as HCO 3 Ϫindependent amiloride-sensitive acid extrusion after an NH 4 ϩ prepulse ( Figure 2B and C). Vascular smooth muscle cells from NBCn1 KO mice displayed larger Na ϩ /H ϩ -exchange activity than VSMCs from WT mice ( Figure 2B , C, and E). Amiloridesensitive base uptake in VSMCs from NBCn1 KO mice was not significantly different in the presence [J base ϭ13.6 mmol/ (L ⅐ min); nϭ5] or absence [J base ϭ15.0 mmol/(L ⅐ min); nϭ5; Pϭ0.42] of CO 2 /HCO 3 Ϫ ( Figure 2C ). Without CO 2 /HCO 3 Ϫ , the NHE1-selective inhibitor cariporide (1 mol/L) caused a larger decrease of VSMC steady-state pH i in arteries from NBCn1 KO (⌬pH i ϭϪ0.15Ϯ0.01; nϭ5) than WT mice (⌬pH i ϭϪ0.09Ϯ 0.02; nϭ5; PϽ0.05). These results support the conjecture that NHE1 is responsible for Na ϩ /H ϩ exchange in VSMCs of mouse mesenteric arteries. 33 In VSMCs from NBCn1 KO mice, we demonstrate a compensatory increase in Na ϩ /H ϩexchange activity which is however insufficient to normalize steady-state pH i . Figure IV ). We showed previously that 600 mol/L amiloride or 1 mol/L cariporide eliminates any change in pH i after Na ϩ removal with CO 2 /HCO 3 Ϫ absent. 33 With CO 2 /HCO 3 Ϫ and 600 mol/L amiloride present, acidification on Na ϩ removal was abolished in ECs from NBCn1 KO mice ( Figure 3A and B). After removal of bath Na ϩ , pH i of ECs from WT mice approached pH i of ECs from NBCn1 KO mice ( Figure 3A ), suggesting that transport by NBCn1 is inhibited but not reversed by extracellular Na ϩ removal.
Regulation of pH i in ECs
With CO 2 /HCO 3 Ϫ present, EC steady-state pH i was 0.25Ϯ0.08 pH units lower in arteries from NBCn1 KO compared with WT mice ( Figure 3C ). Without CO 2 /HCO 3 Ϫ , steadystate pH i was similar in ECs from WT and NBCn1 KO mice ( Figure 3C ). These data provide evidence that NBCn1 is the only active Na ϩ ,HCO 3 Ϫ cotransporter in ECs and no other Na ϩ ,HCO 3 Ϫ cotransporter compensates for the KO of NBCn1. With CO 2 /HCO 3 Ϫ absent, the rate and extent of acidification on Na ϩ removal and the rate of pH i recovery on Na ϩ readdition were significantly increased in ECs from NBCn1 KO compared with WT mice ( Figure 3D through F), suggesting a compensatory increase in Na ϩ /H ϩ -exchange activity. Despite this, no increase in NHE1 protein expression was found in mesenteric arteries from NBCn1 KO mice by Western blot analyses (online-only Data Supplement Figure V ).
Relaxation of Isolated Arteries
Endothelium-dependent relaxation to acetylcholine was Ϸ30% reduced in arteries from NBCn1 KO compared with WT mice with CO 2 /HCO 3 Ϫ present ( Figure 4A and B and online-only Data Supplement Figure VI) , whereas no difference was seen without CO 2 /HCO 3 Ϫ ( Figure 4F ). The difference in relaxation with CO 2 /HCO 3 Ϫ present was abolished by 100 mol/L NO-synthase inhibitor N-nitro-L-arginine methyl ester (L-NAME; Figure 4C and D), and the L-NAMEsensitive relaxation was reduced in arteries from NBCn1 KO mice under these conditions ( Figure 4E ). Without CO 2 / 
HCO 3
Ϫ , relaxation to acetylcholine was impaired ( Figure  4F ), but no difference in L-NAME-sensitive or L-NAMEinsensitive vasorelaxation was observed ( Figure 4G -H) between arteries from NBCn1 KO and WT mice. These data suggest that the low pH i in ECs from NBCn1 KO mice inhibits NO-mediated relaxations.
The responsiveness of VSMCs to NO was investigated by exposing norepinephrine-precontracted arteries to NO-donor S-nitroso-N-acetylpenicillamine. No difference in the relaxant response to NO-donor S-nitroso-N-acetylpenicillamine was found between arteries from NBCn1 KO and WT mice with or without CO 2 /HCO 3 Ϫ (Pϭ0.73; Figure 5A ). Our findings therefore suggest reduced endothelial NO production in NBCn1 KO mice. In accordance with these findings, measurements with NO-sensitive electrodes indicated smaller acetylcholine-induced increases in intraluminal NO concentration in arteries from NBCn1 KO compared with WT mice ( Figure 5B ). Nitric oxide-synthase inhibitor asymmetrical dimethylarginine (300 mol/L) completely abol-ished the acetylcholine-stimulated increase in intraluminal NO concentration ( Figure 5B ).
Reduced NO bioavailability caused by an increased oxidative stress would provide an alternative explanation for the reduced L-NAME-sensitive vasorelaxation in arteries from NBCn1 KO mice. Scavenging of superoxide using polyethylene glycol superoxide dismutase (PEG-SOD; 200 U/mL) increased acetylcholine-induced relaxations more in arteries from WT than NBCn1 KO mice ( Figure 5C ). Consequently, vasorelaxation to acetylcholine in the presence of PEG-SOD was greater in arteries from WT than NBCn1 KO mice ( Figure 5D ). Similarly, the difference in relaxant response between arteries from NBCn1 KO and WT mice persisted after treatment with 100 mol/L of the cell-permeant SOD mimetic tempol ( Figure 5D ). These findings are consistent with previous reports that alkalinization rather than acidification promotes superoxide production 34 and support the conjecture that reduced NO production rather than reduced NO bioavailability explains the reduced NO-mediated relax- Ϫ . D, No difference in relaxations to acetylcholine were seen between arteries from NBCn1 KO and WT mice (nϭ10 -12) after treatment with 100 mol/L L-NAME in the presence of CO 2 /HCO 3 Ϫ . E, N-nitro-L-arginine methyl ester-sensitive relaxations (difference between relaxations before and after L-NAME treatment) were smaller in arteries from NBCn1 KO than WT mice (nϭ10 -12) with CO 2 / HCO 3 Ϫ present. F, With CO 2 /HCO 3 Ϫ absent, no difference in relaxation to acetylcholine was seen between norepinephrineprecontracted arteries from NBCn1 KO and WT mice (nϭ7-11). G, No difference in relaxation to acetylcholine was seen between norepinephrine-precontracted arteries from NBCn1 KO and WT mice (nϭ7-11) after treatment with 100 mol/L L-NAME in the absence of CO 2 /HCO 3 Ϫ . H, With CO 2 /HCO 3 Ϫ absent, no difference in L-NAME-sensitive relaxations (difference between relaxations before and after L-NAME treatment) were seen between arteries from NBCn1 KO and WT mice (nϭ7-11). Comparisons were made with repeated measures 2-way ANOVA followed by Bonferroni post tests. *PϽ0.05, **PϽ0.01, ***PϽ0.001, NE indicates norepinephrine; ACh, acetylcholene; L-NAME, N-nitro-L-arginine methyl ester; and NS, not significantly different versus WT. ations in arteries from NBCn1 KO mice. Reduced eNOS activity was further confirmed by the finding that L-NAMEsensitive conversion of L-[ 14 C]arginine was greatly attenuated in isolated aortic segments from NBCn1 KO compared with WT mice during stimulation with 3 mol/L acetylcholine ( Figure 5E ).
Reduced NO production can arise from reduced eNOS expression or lower activity of the expressed enzyme. Western blot analyses showed no difference in eNOS expression between arteries from NBCn1 KO and WT mice ( Figure 6A ). Also, phosphorylation of eNOS at Ser-1177 was not significantly different between arteries from NBCn1 KO and WT mice ( Figure 6B ). The endothelial intracellular Ca 2ϩ response, which is important for acetylcholine signaling and eNOS activation, was not significantly different between arteries from NBCn1 KO and WT mice ( Figure 6C through E). With CO 2 /HCO 3 Ϫ absent, the endothelial intracellular Ca 2ϩ response was equally attenuated in arteries from NBCn1 KO and WT mice ( Figure 6D and E) , likely accounting for the smaller acetylcholine-induced relaxations seen under these conditions ( Figure 4F ). These findings provide evidence that KO of NBCn1 results in reduced acetylcholineinduced NO production through a pH i -mediated intracellular Ca 2ϩ -independent inhibition of eNOS activity.
Contraction of Isolated Arteries
Tension development to norepinephrine was not significantly different between arteries from NBCn1 KO and WT mice in the presence of CO 2 /HCO 3 Ϫ ( Figure 7A ). Incubation with 100 mol/L L-NAME did not affect resting artery tone, but increased the sensitivity of arteries from WT mice to norepinephrine with respect to tension development ( Figure 7A ). In arteries from NBCn1 KO mice, this increase in norepinephrine sensitivity was strongly reduced ( Figure 7A ), suggesting that basal and/or norepinephrine-stimulated NO production is reduced and unmasking a difference in VSMC contractility Ϫ present, the difference in vasorelaxation between arteries from NBCn1 KO and WT mice persisted after superoxide scavenging with 200 U/mL PEG-SOD (Di; nϭ5-6) or 100 mol/L tempol (Dii; nϭ6). Comparisons were made with repeated measures 2-way ANOVA followed by Bonferroni post tests. E, With CO 2 /HCO 3 Ϫ present, L-NAMEsensitive conversion of L-[ 14 C]arginine during 30 minutes stimulation with 3 mol/L acetylcholine was reduced in intact aortic segments from NBCn1 KO compared with WT mice (nϭ6 -7). Comparison was made with unpaired 2-tailed Student t test. *PϽ0.05, **PϽ0.01, SNAP indicates S-nitroso-N-acetylpenicillamine; ADMA, asymmetrical dimethylarginine; PEG-SOD, polyethylene glycol superoxide dismutase; L-NAME, N-nitro-L-arginine methyl ester; and NS, not significantly different versus WT.
between arteries from NBCn1 KO and WT mice. No difference in the VSMC intracellular Ca 2ϩ response to norepinephrine was seen between arteries from NBCn1 KO and WT mice with L-NAME and CO 2 /HCO 3 Ϫ present ( Figure 7B ). Rho-kinase inhibition with 10 mol/L Y-27632 or fasudil abolished the difference in tension development after L-NAME treatment ( Figure 7A ). Y-27632 did not affect the VSMC intracellular Ca 2ϩ response to norepinephrine ( Figure  7B ). These results show that VSMC Ca 2ϩ sensitivity is reduced in arteries from NBCn1 KO mice in a rho-kinasedependent manner. Consistent with these findings, when Y-27632 was added in the absence of L-NAME, norepinephrine-sensitivity was lower in arteries from WT compared with NBCn1 KO mice ( Figure 7C ). We furthermore showed that phosphorylation of MYPT at Thr-850, which is one of the major targets of the rho-kinase, was decreased in 100 mol/L L-NAME-treated, 1 mol/L norepinephrine-stimulated arteries from NBCn1 KO compared with WT mice ( Figure 7D ). Phosphorylation of MYPT at Thr-850 was reduced by 89Ϯ8% (nϭ5; PϽ0.001 versus control) when mesenteric small arteries from WT mice were pretreated with 10 mol/L Y-27632. Total expression of MYPT relative to pan-actin did not differ between mesenteric small arteries from NBCn1 KO and WT mice (0.87Ϯ0.04 in NBCn1 KO compared with 1.00Ϯ0.10 in WT; nϭ5-6; Pϭ0.21).
Without CO 2 /HCO 3 Ϫ , pH i of both ECs and VSMCs were identical in NBCn1 KO and WT mice ( Figures 2F and 3C ). Under these conditions, L-NAME only slightly increased norepinephrine sensitivity with respect to tension development, and no difference between arteries from NBCn1 KO and WT mice was found ( Figure 7E ). Hence, NBCn1 KO most likely affects tension development because of the defect in pH i regulatory function. Consistent with this, norepinephrine sensitivity of L-NAME-treated arteries from WT mice was reduced with respect to tension development ( Figure 7A and E; PϽ0.05) when VSMCs were acidified by removal of CO 2 /HCO 3 Ϫ ( Figure 2F ). In arteries from NBCn1 KO mice, removal of CO 2 /HCO 3 Ϫ affected neither VSMC pH i ( Figure  2F ) nor tension development to norepinephrine ( Figure 7A and E; Pϭ0.31).
The reason for reduced rho-kinase activity at low VSMC pH i might involve several pH i -affected targets; however, we investigated whether direct effects of pH i on the rho-kinase could play a role. The isolated rho-kinase was pH sensitive with appreciable changes in catalytic activity in a physiologically relevant pH range (online-only Data Supplement Figure VIIa). Deduced from these results, the difference in steady-state pH i between VSMCs from NBCn1 KO and WT mice ( Figure 2F Figure VIIc) , comparable to the difference between L-NAME-treated arteries from NBCn1 KO and WT mice with CO 2 /HCO 3 Ϫ present ( Figure  7A and online-only Data Supplement Table I ). We propose that reduced rho-kinase activity due to a lower VSMC pH i contributes to the reduced VSMC Ca 2ϩ sensitivity in NBCn1 KO mice (online-only Data Supplement Figure VIII) . 
Blood Pressure Regulation
Systemic mean arterial pressure (MAP) of NBCn1 KO mice was 9 to 12 mm Hg higher than that of WT mice whereas no significant difference in heart rate (HR) was observed ( Figure 8A ).
During treatment with L-NAME (100 mg/kg body weight daily) in the drinking water, the increase in MAP was significantly blunted in NBCn1 KO compared with WT mice ( Figure  8B) . The concomitant decrease of HR was also reduced in NBCn1 KO mice ( Figure 8B) , consistent with the blunted blood pressure response causing a smaller baroreflex-mediated inhibition. Daily doses of 600 mg L-NAME per kg body weight gave a similar result (⌬MAP ϭ4.5Ϯ2.5 mm Hg in NBCn1 KO versus 20.2Ϯ4.2 mm Hg in WT mice; nϭ5-6; PϽ0.05). Mean arterial pressure and HR returned to pretreatment levels when mice were given access to water without L-NAME after the treatment period. The MAP increase and HR reduction after L-NAME ingestion have been shown to depend on an active eNOS. 18 Hence, our findings corroborate the finding that NO production is reduced in NBCn1 KO mice and underscore its importance for integrated cardiovascular control.
Vasoconstriction and hypertension development to angiotensin II depend on VSMC rho-kinase activation. 23, 35 Compared with WT mice, NBCn1 KO mice were remarkably resistant to developing hypertension during angiotensin-II infusion ( Figure 8C and D) . Angiotensin II increased HR of NBCn1 KO mice considerably, whereas this effect was partially blunted by an apparent baroreflex-mediated inhibition in WT mice ( Figure 8D ). The differential effects of angiotensin-II infusion were unlikely to be attributed to a difference in aldosterone signaling because the expression of the epithelial sodium channel (ENaC) did not significantly differ between kidneys from NBCn1 KO and WT mice (online-only Data Supplement Figure IX) .
We investigated rho-kinase activity in vivo by intraperitoneal administration of Y-27632, which affects blood pressure regulation through changes in peripheral vascular resistance. 36 The change in MAP after injection of Y-27632 (10 mg/kg body weight) was reduced in NBCn1 KO compared with WT mice when administered alone ( Figure 8E) , to L-NAME-treated (100 mg/kg body weight daily; Figure 8F ), Figure 7 . Arteries from NBCn1 KO mice display impaired resting and/or norepinephrine-induced NO production and lower rho-kinase-dependent Ca 2ϩ sensitivity. A, No difference in tension development to norepinephrine was seen between arteries from NBCn1 KO and WT mice under control conditions with CO 2 /HCO 3 Ϫ present (nϭ14 -15; Pϭ0.08). After treatment with 100 mol/L L-NAME, lower sensitivity to norepinephrine was seen in arteries from NBCn1 KO than WT mice (nϭ10; PϽ0.01). This difference was abolished when L-NAME-treated arteries were incubated with 10 mol/L of the rho-kinase inhibitors Y-27632 (nϭ5-6; Pϭ0.83) or fasudil (nϭ5; Pϭ0.78). B, No difference in average VSMC intracellular Ca 2ϩ response was seen between arteries from NBCn1 KO and WT mice (nϭ5) in the presence of 100 mol/L L-NAME with (Pϭ0.27) or without (Pϭ0.97) 10 mol/L Y-27632. C, With CO 2 /HCO 3 Ϫ present, treatment with 10 mol/L Y-27632 resulted in a greater sensitivity to norepinephrine with respect to tension development in arteries from NBCn1 KO compared with WT mice (nϭ6; PϽ0.01). D, Phosphorylation of MYPT at Thr-850 was reduced in arteries from NBCn1 KO compared with WT mice (nϭ3-7). Representative bands for phosphorylated and total MYPT and results of the densitometric analysis are shown. ϩ/ϩ and -/-denote WT and NBCn1 KO, respectively. Comparison was performed with a 2-way ANOVA and the overall probability value reported. E, With CO 2 /HCO 3 Ϫ absent, no difference in tension development to norepinephrine was seen between arteries from NBCn1 KO and WT mice under control conditions (nϭ13-14; Pϭ0.15) or in the presence of 100 mol/L L-NAME (nϭ5-6; Pϭ0.72). Log(EC 50 ) and maximum values were derived from sigmoidal curve fits, compared with extra sum-of-squares F tests, and reported in online-only Data Supplement Table I . *PϽ0.05. L-NAME indicates N-nitro-L-arginine methyl ester; MYPT, myosin phosphatase targeting subunit.
or to angiotensin-II-treated mice ( Figure 8G ). The parallel increase in HR was also attenuated in NBCn1 KO mice ( Figure 8F) . The MAP and HR changes after intraperitoneal saline injection were not significantly different between NBCn1 KO and WT mice ( Figure 8F ). Our results are consistent with reduced rho-kinase-dependent VSMC Ca 2ϩ sensitivity altering blood pressure control in NBCn1 KO mice.
Discussion
We describe a novel role for transmembrane acid-base movement in NO-mediated vasorelaxation, rho-kinasedependent VSMC Ca 2ϩ sensitivity, and blood pressure regulation. The signaling pathways proposed to be affected by pH i after NBCn1 KO are summarized in online-only Data Supplement Figure VIII . Previously, sustained pH i changes have been difficult to induce experimentally, and as a Figure 8 . NBCn1 KO mice are mildly hypertensive at rest, display attenuated blood pressure responses to NO synthase and rho-kinase inhibition, and are resistant to developing hypertension to angiotensin II. A, Resting MAP was higher in NBCn1 KO compared with WT mice whereas resting HR was not different. The effect was seen with radiotelemetry (Ai, nϭ12-14) and tail-cuff (Aii; nϭ19 -22) measurements. B, The increase in MAP and the concomitant change in HR on treatment with L-NAME in the drinking water were attenuated in NBCn1 KO compared with WT mice (nϭ12-14). N-nitro-L-arginine methyl ester intake relative to body weight was not different between NBCn1 KO and WT mice. C, Average MAP before and during continuous angiotensin-II infusion in NBCn1 KO and WT mice (nϭ7-8). D, The MAP increase during angiotensin-II infusion was reduced and the HR increase augmented in NBCn1 KO compared with WT mice (nϭ7-8). E, The change in MAP after i.p. injection of 10 mg Y-27632 per kg body weight was smaller in NBCn1 KO compared with WT mice. The star denotes significant interaction (ie, the effect of Y-27632 was significantly different between NBCn1 KO and WT mice; comparison was made with repeated measures 2-way ANOVA). F, The change in MAP after i.p. injection of 10 mg Y-27632 per kg body weight was smaller in L-NAME-treated NBCn1 KO than WT mice and the parallel increase in HR attenuated. The effect was seen with radiotelemetry (Fi; nϭ5-7) and tail-cuff (Fii; nϭ7-8) measurements. The stars in the left panel denote significant interaction (ie, the effect of Y-27632 was significantly different between NBCn1 KO and WT mice; comparison was made with repeated measures 2-way ANOVA). No difference in MAP and HR changes were seen between NBCn1 KO and WT mice after i.p. saline injection. G, The change in MAP after i.p. injection of 10 mg Y-27632 per kg body weight was attenuated in angiotensin-II-treated NBCn1 KO compared with WT mice (nϭ5-8). Comparisons were made with unpaired 2-tailed Student t tests. *PϽ0.05, **PϽ0.01, ***PϽ0.001. MAP indicates mean arterial pressure; HR, heart rate; and NS, not significantly different versus WT.
consequence vascular effects of maintained pH i disturbances have largely been unknown. We used functional genetics to inactivate NBCn1, impede pH i regulation in ECs and VSMCs, and study the importance of a normal pH i level for blood pressure control and mesenteric artery function, which contributes to peripheral vascular resistance. 37 The catalytic activity of isolated NO synthase displays a bell-shaped pH dependency, with an optimum level around pH 7.5 and prominent changes in the physiological pH i range. 10 Direct inhibition of eNOS activity by low EC pH i is of sufficient magnitude to quantitatively account for the changes in acetylcholine-induced vasorelaxation observed in the present study. We propose that intracellular acidification after KO of NBCn1 inhibits NO production because eNOS is intrinsically pH sensitive.
Although large acute changes in VSMC pH i produce dramatic changes in artery tone, 38 -40 the effects of smaller and sustained changes in VSMC pH i appear more subtle. Studies using chemical permeabilization describe pH-induced changes in VSMC Ca 2ϩ sensitivity, but with conflicting reports as to whether the sensitivity is increased or decreased with acidification. 15, 16 Recently, we suggested that sustained intracellular acidification reduces VSMC Ca 2ϩ sensitivity during norepinephrine stimulation. 9 Our current findings support this and suggest an effect on rho-kinase signaling.
We find that isolated rho-kinase displays an intrinsic pH sensitivity of a magnitude sufficient to explain the reduced norepinephrine sensitivity of arteries from NBCn1 KO mice. Although there is considerable cross-talk between the NO and the rho-kinase signaling pathways, [41] [42] [43] reduced VSMC Ca 2ϩ sensitivity and lower NO production in arteries from NBCn1 KO mice do not appear to be interdependent. Firstly, the reduced effect of rho-kinase inhibition in arteries from NBCn1 KO mice was observed both before and after L-NAME treatment (ie, even when NO production is abolished). Secondly, according to previous reports, reduced concentrations of NO enhance rho-kinase activity and Ca 2ϩ sensitivity, 42, 43 whereas rho-kinase inhibition increases eNOS activity. 41 For these reasons, our findings suggest lower VSMC Ca 2ϩ sensitivity in arteries from NBCn1 KO mice caused by pH i -mediated inhibition of the rho-kinase signaling pathway independently of the simultaneous reduction in endothelial NO production.
Importantly, the differences in pH i and the functional differences between arteries from WT and KO mice were abolished in the absence of CO 2 /HCO 3 Ϫ . This strongly implicates pH i rather than secondary changes consequent to the prolonged KO as the cause of the functional changes.
Acid-base disturbances are common clinical manifestations of metabolic, renal, and pulmonary disease. Intracellular acidification may also develop secondary to ischemia or possibly as a consequence of genetic mutations in NBCn1. It is plausible that such pH i disturbances contribute to differences in cardiovascular susceptibility among individuals, and the described pH i -mediated effects on artery function and blood pressure control provide a novel target to consider for future treatment strategies.
In conclusion, this study provides the first direct evidence that membrane acid-base transport is crucial for artery function and blood pressure regulation. Knockout of NBCn1 acidifies mesenteric artery ECs and VSMCs, inhibits NO-mediated relaxations, and diminishes rho-kinase-dependent VSMC Ca 2ϩ sensitivity. In agreement with the changes in artery function, we show that NBCn1 KO mice are mildly hypertensive at rest, display attenuated blood pressure responses to NO synthase and rho-kinase inhibition, and are resistant to developing hypertension during angiotensin-II infusion.
